7        inflammation and coagulation                

Aderka D  (1991) Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications. abstract  Isr J Med Sci 27(1):52-60

Amstutz P, Moyo JS (1996) Disseminated intravascular coagulations. abstract  Cah Anesthesiol  44(3):219-28 

Bajaj SP, Joist JH (1999) New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy. abstract Semin Thromb Hemost 25(4):407-18

Carson SD, Johnson DR  (1990)   Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity.  abstract  Blood  15;76(2):361-7  ---------------related articles

Esmon CT (1999) Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. abstract  Baillieres Best Pract Res Clin Haematol 12(3):343-59  

Esmon CT (2000) The Anticoagulant and Anti-inflammatory Roles of the Protein C Anticoagulant Pathway. abstract   J Autoimmun 15(2):113-116 ---------------related articles

Esmon  CT (2000) Regulation of blood coagulation.  abstract  Biochim Biophys Acta 7;1477(1-2):349-60  

Mammen EF (1998) Antithrombin: its physiological importance and role in DIC.  abstract  Semin Thromb Hemost 24(1):19-25 

Nielsen JD (1998)  The effect of antithrombin on the systemic inflammatory response in disseminated intravascular coagulation.  abstract  Blood Coagul Fibrinolysis 9 Suppl 3:S11-5  

Ogata M, Fletcher MF, Kloczewiak M, Loiselle PM, Zanzot EM, Vermeulen MW, Warren HS. (1997) Effect of anticoagulants on binding and neutralization of lipopolysaccharide by the peptide immunoglobulin conjugate CAP18(106-138)-immunoglobulin G in whole blood. abstract  full text-download   Infect Immun 65(6):2160-7 

Okajima K (1998) Antithrombin prevents endotoxin-induced pulmonary vascular injury by inhibiting 
leukocyte activation.  abstract  Blood Coagul Fibrinolysis  Suppl 2:S25-37 

Pulletz S; Lehmann C; Volk T; Schmutzler M; Ziemer S; Kox WJ; Scherer RU (2000) Influence of heparin and hirudin on endothelial binding of antithrombin in experimental thrombinemia. abstract Crit Care Med 28(8):2881-6

Schmidt-Supprian M, Murphy C, While B, Lawler M, Kapurniotu A, Voelter W, Smith O, Bernhagen J (2000) Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes. abstract Eur Cytokine Netw 11(3):407-13   ---------------related articles

Tedesco F, Pausa M, Nardon E, Introna M, Mantovani A, Dobrina A (1997) The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity.  abstract  J Exp Med 5;185(9):1619-27 

Uchiba M; Okajima K (1997) Antithrombin III (AT III) prevents LPS-induced pulmonary vascular injury: novel biological activity of AT III. abstract  Semin Thromb Hemost 23(6):583-90

White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, Lawler M, O'Neill L, Kelleher D, Schwarz HP, Smith OP (2000) Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. abstract  Br J Haematol 110(1):130-4